Companies

Journey Medical Corp (DERM) SEC filings

CIK 0001867066 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)61.9 M79.2 M73.7 M
Net income (USD)-11.4 M-3.9 M-29.6 M
Diluted EPS (USD/shares)-0.47-0.21-1.69

Latest filings

FiledFormDescriptionPeriod
2026-10-09SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1210-Q10-Q2026-06-30
2026-08-128-KFORM 8-K items 2.02,9.012026-08-12
2026-07-31SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-024OWNERSHIP DOCUMENT2026-07-01
2026-07-024OWNERSHIP DOCUMENT2026-07-01
2026-07-024OWNERSHIP DOCUMENT2026-07-01
2026-06-294OWNERSHIP DOCUMENT2026-06-25
2026-06-264OWNERSHIP DOCUMENT2026-06-25
2026-06-264OWNERSHIP DOCUMENT2026-06-25
2026-06-264OWNERSHIP DOCUMENT2026-06-25
2026-06-264OWNERSHIP DOCUMENT2026-06-25
2026-06-268-KFORM 8-K items 5.072026-06-24
2026-05-1310-Q10-Q2026-03-31
2026-05-138-KFORM 8-K items 2.02,9.012026-05-13
2026-04-30DEFA14ADEFA14A
2026-04-30DEF 14ADEF 14A2026-06-24
2026-04-30SCHEDULE 13GSCHEDULE 13G
2026-04-244OWNERSHIP DOCUMENT2026-04-22
2026-04-244OWNERSHIP DOCUMENT2026-04-22
2026-04-244OWNERSHIP DOCUMENT2026-04-22
2026-04-218-KFORM 8-K items 8.01,9.012026-04-21
2026-04-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-2610-K10-K2025-12-31

Forms on file (last 1,000): 4 75, 8-K 48, 10-Q 15, 3 11, UPLOAD 9, CORRESP 8, SCHEDULE 13G/A 6, DEFA14A 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DERM (0.002 USD), /gw/filings/filings?ticker=DERM&form=8-K, /gw/filings/facts?ticker=DERM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange